Finally, one trial (Adams et al. 2004) reported that a symptom-limited test using a cycle ergometer resulted in a significant elevation of CD34+/KDR+ EPCs by 164% at 24 h and by 76% at 48 h in an ischaemic CAD group. The gene discussed is KDR; the disease is coronary artery disorder.